Xarelto (Rivaroxaban) J&J Anti Clot Trials Looking Good

Johnson & Johnson's blood clot preventer Xarelto has come out well in clinical trials, with results comparable to other treatments for blood clotting in the lungs. A study of nearly 5000 patients showed effectiveness and safety were on par with anything else on the market, meaning the drug is poised to move forwards and possibly become a front-runner for hospitals around the world. The generally accepted treatment used, a combination injection of heparin and warfarin in pill form, was compared with Xarelto...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/-jBset3tkYk/243444.php

news auto sport medical